Evidence map›Paper›PMID 42181633›Full record

ArticleFrontiers in cardiovascular medicine2026

Association of

Anna Kalinskaya, Oleg Dukhin, George Rusakovich, Alexandra Anisimova, Elena Maryukhnich, Daria Vorobyeva, Oxana Ivanova, Polina Gavrilina, Yulia Sukhikh, Anna Gumbina and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Anna Kalinskaya *Laboratory of Atherothrombosis, Cardiology Department, Federal State Budgetary Educational Institution of Higher Education Russian University of Medicine of the Ministry of Health of the Russian Federation, Moscow, Russia.
Oleg Dukhin *Laboratory of Atherothrombosis, Cardiology Department, Federal State Budgetary Educational Institution of Higher Education Russian University of Medicine of the Ministry of Health of the Russian Federation, Moscow, Russia.
George RusakovichI.V. Davydovsky City Clinical Hospital, Moscow Department of Healthcare, Moscow, Russia.
Alexandra AnisimovaLaboratory of Atherothrombosis, Cardiology Department, Federal State Budgetary Educational Institution of Higher Education Russian University of Medicine of the Ministry of Health of the Russian Federation, Moscow, Russia.
Elena MaryukhnichLaboratory of Atherothrombosis, Cardiology Department, Federal State Budgetary Educational Institution of Higher Education Russian University of Medicine of the Ministry of Health of the Russian Federation, Moscow, Russia.
Daria VorobyevaLaboratory of Atherothrombosis, Cardiology Department, Federal State Budgetary Educational Institution of Higher Education Russian University of Medicine of the Ministry of Health of the Russian Federation, Moscow, Russia.
Oxana IvanovaLaboratory of Atherothrombosis, Cardiology Department, Federal State Budgetary Educational Institution of Higher Education Russian University of Medicine of the Ministry of Health of the Russian Federation, Moscow, Russia.
Polina GavrilinaLaboratory of Atherothrombosis, Cardiology Department, Federal State Budgetary Educational Institution of Higher Education Russian University of Medicine of the Ministry of Health of the Russian Federation, Moscow, Russia.
Yulia SukhikhLaboratory of Atherothrombosis, Cardiology Department, Federal State Budgetary Educational Institution of Higher Education Russian University of Medicine of the Ministry of Health of the Russian Federation, Moscow, Russia.
Anna GumbinaLaboratory of Atherothrombosis, Cardiology Department, Federal State Budgetary Educational Institution of Higher Education Russian University of Medicine of the Ministry of Health of the Russian Federation, Moscow, Russia.
Sofya ZaitsevaLaboratory of Atherothrombosis, Cardiology Department, Federal State Budgetary Educational Institution of Higher Education Russian University of Medicine of the Ministry of Health of the Russian Federation, Moscow, Russia.
Elena VasilievaLaboratory of Atherothrombosis, Cardiology Department, Federal State Budgetary Educational Institution of Higher Education Russian University of Medicine of the Ministry of Health of the Russian Federation, Moscow, Russia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The patency of the infarct-related artery (IRA) is known to be associated with clinical outcomes in acute myocardial infarction (AMI). It is known that the presence of impaired coronary blood flow in the acute phase of the disease may worsen the course of the AMI. Despite its great importance, the precise determinants of the IRA blood flow remain incompletely understood. Methods: A total of 255 AMI patients were included in this study: 169 with impaired (TIMI 0-I) and 86 with preserved (TIMI II-III) coronary blood flow. All patients underwent complete hemostasis profiling, including rotational thromboelastometry, impedance aggregometry and thrombodynamics and were assessed for various in- and out-of-hospital AMI-related complications. Results: TIMI 0-I patients were characterized by an enhanced Conclusion: The present study identified several hemostatic parameters associated with both IRA patency and clinical course of AMI. These findings indicate a more pronounced prothrombotic state in patients with reduced coronary blood flow, and further research is required to translate these findings into clinical practice.

Indexed as

clot formationcoronary blood flowmyocardial infarctionspontaneous reperfusionthrombosis

Identifiers

PMID42181633
PMCPMC13190566

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.